IFN-alpha and novel strategies of combination therapy for cancer

scientific article published on 13 June 2007

IFN-alpha and novel strategies of combination therapy for cancer is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1196/ANNALS.1415.030
P698PubMed publication ID17567945

P2093author name stringEnrico Proietti
Filippo Belardelli
Laura Bracci
P2860cites workThe nature of the principal type 1 interferon-producing cells in human bloodQ29619763
Interferon-alpha in tumor immunity and immunotherapyQ34568695
Leveraging the activity of tumor vaccines with cytotoxic chemotherapyQ36258579
Type I interferons keep activated T cells aliveQ36367751
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.Q36368488
Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alphaQ36371335
Type I interferon in systemic lupus erythematosus and other autoimmune diseasesQ36595839
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeQ40591372
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Type I interferon-mediated stimulation of T cells by CpG DNAQ41824775
The role of MyD88 and TLR4 in the LPS-mimetic activity of TaxolQ43704400
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentQ43948384
Prognostic significance of autoimmunity during treatment of melanoma with interferon.Q44019499
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.Q44550766
Induction of bystander T cell proliferation by viruses and type I interferon in vivoQ46486509
International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?Q53284971
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.Q53718320
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferonQ57275922
Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-αQ57791171
P407language of work or nameEnglishQ1860
P304page(s)256-268
P577publication date2007-06-13
P1433published inAnnals of the New York Academy of SciencesQ2431664
P1476titleIFN-alpha and novel strategies of combination therapy for cancer
P478volume1112

Reverse relations

cites work (P2860)
Q39609067Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation
Q90419584Current Perspectives in Cancer Immunotherapy
Q41901253GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma.
Q41958567IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases
Q34204603PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH₂-terminal kinase activation
Q57159202Perspectives on interferon-alpha in the treatment of Polycythemia vera and related Myeloproliferative neoplasms: minimal residual disease and cure?